Lung Cancer Screening More Efficient for Those at Higher Risk
Initial screens were least effective and least efficient for veterans with lowest lung cancer risk, according to this study.
Initial screens were least effective and least efficient for veterans with lowest lung cancer risk, according to this study.
In lung cancer, it is critical to evaluate the resistance mechanisms so appropriate treatment can be administered.
Study findings presented at SABCS 2017 demonstrate that intermediate Oncotype DX scores are prognostic of overall survival for patients with early-stage breast cancer, particularly in younger women with the disease.
The use of flow cytometry has demonstrated usefulness in multiple myeloma recurrence assessment.
An endoscopic imaging tool in development could aid diagnosis of cancer without the delay of pathologic review of tissue sampling and staining.
MIT team develops simple, less painful diagnostic test for multiple myeloma using microfluidic chip and conventional blood sample.
Two-gene pigmented lesion test classifies skin lesions as melanoma or nonmelanoma, helping with diagnostic challenges faced with the visual image and pattern recognition approach.
A new blood test employs a type of DNA signature to locate the presence of tumor in a particular tissue, avoiding the need for invasive diagnostic procedures.
Novel diagnostic test determines whether suspicious lung lesions or nodules are malignant disease from a sample obtained via nasal swab.
Study identifies physician and patient preferences about information, who should communicate this information, and what guidelines should guide these discussions.